IMA910 PLUS GM-CSF WITH LOW-DOSE CYCLOPHOSPHAMIDE PRE-TREATMENT IN ADVANCED COLORECTAL CARCINOMA PATIENTS FOLLOWING A SUCCESSFUL 12 WEEK FIRST-LINE TREATMENT WITH OXALIPLATIN-BASED CHEMOTHERAPY (IMA910-101):